Kezad Communities, in a notable partnership with Burjeel Holdings, is set to revolutionize healthcare accessibility in the Razeen workers’ cities. The new onsite healthcare clinic, part of the Khalifa Economic Zones Abu Dhabi (Kezad) Group initiative, aims to provide comprehensive medical services directly to the residents of Razeen 3 and 4 complexes.
This flagship project will offer essential medical services including paramedics, 24/7 nursing care, and a round-the-clock ambulance service. The collaboration is a significant step in Kezad Communities’ commitment to improving the well-being of its community members through advanced healthcare solutions.
Razeen, with the capacity to house 25,000 residents, will greatly benefit from the clinic’s presence. The facility will feature a team of experienced general physicians, providing primary, emergency, and preventive care, as well as continuous nursing assistance. In cases requiring specialized treatment, the clinic will facilitate referrals to Burjeel Holdings’ network of super-speciality hospitals.
The Memorandum of Understanding (MoU) for the establishment of the clinic was signed by Hamad Ahmed Al Hosani, Burjeel brand’s Chief Corporate Officer, and Abdul Aziz A. Bawazeer, CEO of Kezad Communities. The signing was witnessed by Omran Al Khoori, Burjeel Holdings’ Board Member and President of Business Development, and Abdullah Al Hameli, CEO of Economic Cities and Free Zones at AD Ports Group.
Abdul Aziz A. Bawazeer remarked that the clinic is a “key milestone” in realizing Kezad’s vision for the Razeen cities. “We are proud to offer this facility, symbolizing our dedication to fostering a safe and nurturing environment for our community in line with the vision of our leadership,” he stated.
John Sunil, CEO of Burjeel Holdings, emphasized the clinic’s role in addressing the healthcare needs of Razeen residents, ensuring unparalleled access to top-tier medical care within their community.
Following the 2023 merger with Al Eskan Al Jamae, Kezad Communities now owns and manages a capacity of 135,000 beds and holds regulatory oversight over 420,000 beds, marking a significant expansion in their operational scope.
